Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through ...

Amid a challenging climate for Vancouver’s life sciences sector, Zymeworks Inc. (Nasdaq:ZYME) stands out as a success story ...

Management has positioned bezuclastinib as a potential alternative to Blueprint Medicines' (BPMT) Ayvakit. This PDGFRα/c-KIT ...

Clearmind Medicine shares dropped in after-hours trading following the company's announcement of a 1-for-40 reverse stock ...

AI powers digital twins of cells/molecules, speeding early drug discovery and cutting trial-and-error work. Read more here.

Existing IPF treatments, including Boehringer’s recently approved Jascayd, slow disease progress rather than halt or reverse ...

Boqii shares surged in after-hours trading following the announcement of a $1.76 million equity repurchase by the founders of ...

Capricor Therapeutics (CAPR) stock is the best stock on Wall Street and burning short sellers after upbeat drug data ...

EST Moleculin Biotech (MBRX) trading halted, news pending Published first on TheFly – the ultimate source for real-time, market-moving ...

But sometimes, this top investor who focuses on innovation does see eye-to-eye with analysts, and the perfect example of this ...

Argenica Therapeutics shares have surged higher after positive clinical trial results for its stroke treatment drug.

RA Capital Management’s Peter Kolchinsky says the companies that survived the industry’s 2021 rout are thriving—and looking ...